Lung cancer is the second most common cancer; however, it often is not diagnosed until the advanced stages. Early-stage lung cancer is curable, but screening tools are not usually implemented in practice because of a lack of provider awareness. A lung cancer screening decision aid may increase screening use and, ultimately, reduce lung cancer deaths.
At a Glance
- Lung cancer screening decreases mortality.
- Informed decision making is crucial in optimizing screening.
- A majority of prescribers surveyed believe that the lung cancer screening decision aid described in this article is beneficial to their patients.
Not a current ONS member or journal subscriber?
Receive a PDF to download and print.
Development and Evaluation of a Lung Cancer Screening Decision Aid
has been added to your cart